Substance Use to Cope with Stigma in Healthcare Among U.S. Female-to-Male Trans Masculine Adults

LGBT Health
Sari L ReisnerColton L Keo-Meier

Abstract

Enacted and anticipated stigma exist within healthcare settings for transgender people, but research has yet to examine the effects of these forms of stigma on the substance use behaviors of female-to-male (FTM) trans masculine people. Data were analyzed from the cross-sectional U.S. National Transgender Discrimination Survey, a convenience sample of transgender adults purposively sampled in 2008. Trans masculine respondents (n=2,578) were identified using a two-step method: Step 1, Assigned birth sex; Step 2, Current gender identity. A gender minority stress model of substance use was tested to examine the relation of enacted and anticipated stigma with substance use to cope with mistreatment. Overall, 14.1% of the sample reported having been refused care by a provider (enacted stigma), 32.8% reported delaying needed medical care when sick/injured, and 39.1% delayed routine preventive care (anticipated stigma). Having been refused care was significantly associated with avoidance of healthcare, including delaying needed medical care when sick/injured and delaying routine preventive medical care. Substance use to cope with mistreatment was self-reported by 27.6% of the sample. Enacted stigma by providers was associated with self...Continue Reading

References

Jun 24, 1999·International Journal of Health Services : Planning, Administration, Evaluation·N Krieger
Apr 8, 2004·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Jul 1, 2005·American Journal of Epidemiology·Donna Spiegelman, Ellen Hertzmark
Jun 8, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Emily NewfieldLori Kohler
Dec 1, 2006·Journal of Homosexuality·Kristen Clements-NolleMitchell Katz
Jan 29, 2010·American Journal of Epidemiology·Katherine J Lee, John B Carlin
Dec 22, 2010·Journal of Health and Social Behavior·Jo C PhelanParisa Tehranifar
Sep 20, 2012·Journal of Sex Research·Charlotte Chuck TateCris P Youssef
Jan 12, 2013·Archives of Sexual Behavior·S Colton MeierJulia Babcock
Mar 16, 2013·American Journal of Public Health·Walter O BocktingEli Coleman
Aug 6, 2013·Perspectives in Public Health·Adam M LeventhalGenevieve F Dunton
Aug 22, 2013·Journal of the American Psychiatric Nurses Association·Sari L ReisnerSel Hwahng
Feb 25, 2014·Addictive Behaviors·Annesa FlentjeJames L Sorensen
Aug 15, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Dixon ChibandaMelanie Abas

❮ Previous
Next ❯

Citations

Jan 13, 2016·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Sari L ReisnerMatthew J Mimiaga
Nov 26, 2015·Social Science & Medicine·Jaclyn M White HughtoJohn E Pachankis
Jul 15, 2015·Journal of General Internal Medicine·Jennifer PotterDana J Pardee
Feb 8, 2020·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Branden T BargerAnnesa Flentje
Jun 3, 2020·AIDS Patient Care and STDs·Valerie A EarnshawSeth C Kalichman
Aug 14, 2020·Behavioral Medicine·Corina Lelutiu-WeinbergerPriyadharshiny Sandanapitchai
Nov 7, 2019·International Journal of Health Services : Planning, Administration, Evaluation·Cemile Hurrem Balik AyhanSevim Buzlu
Apr 7, 2017·Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society·Jaclyn M White Hughto, Sari L Reisner
Apr 16, 2019·Addiction Science & Clinical Practice·Paul J JoudreyAaron D Fox
Sep 5, 2019·Transgender Health·Jessamyn BowlingChloe Vercruysse
Oct 6, 2020·International Journal of Transgender Health·Austin H JohnsonAndrew Bradford
Jun 14, 2019·Addictive Behaviors Reports·Anna Martha Vaitses FontanariMaria Inês Rodrigues Lobato
Feb 1, 2020·American Journal of Preventive Medicine·Meghan Romanelli, Michael A Lindsey
Aug 21, 2021·Transgender Health·Louis LindleyM Paz Galupo

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.